Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Intermediate lymphocytic lymphoma].

P Kończalik1, E Hyjek

  • 1II Kliniki Chorób Wewnetrznych Instytutu Medycyny Wewnetrznej Ak. Med., Lodzi.

Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|February 1, 1992
PubMed
Summary

Intermediate lymphocytic lymphomas present unique pathomorphological and clinical features, occurring in diffuse and nodular forms. These lymphomas share traits with chronic lymphocytic leukemia but exhibit a more aggressive clinical course.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ICSH guidelines for the standardization of bone marrow immunohistochemistry.

International journal of laboratory hematology·2015
Same author

Call for a European programme in external quality assurance for bone marrow immunohistochemistry; report of a European Bone Marrow Working Group pilot study.

Journal of clinical pathology·2009
Same author

BCL-6 protein is expressed in precursor T-cell lymphoblastic lymphoma and in prenatal and postnatal thymus.

Blood·2001
Same author

Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration.

The Journal of clinical investigation·2000
Same author

Identification of critical, conserved vicinal aspartate residues in mammalian and bacterial ADP-ribosylarginine hydrolases.

The Journal of biological chemistry·1999
Same author

Characterization of NAD:arginine ADP-ribosyltransferases.

Molecular and cellular biochemistry·1999

Area of Science:

  • Hematopathology
  • Oncology
  • Lymphoid Neoplasms

Context:

  • Lymphomas represent a diverse group of lymphoid malignancies.
  • Intermediate lymphocytic lymphoma (ILL) is a distinct clinicopathological entity.
  • Understanding the nuances of ILL is crucial for accurate diagnosis and treatment.

Purpose:

  • To delineate the characteristic pathomorphological and clinical features of intermediate lymphocytic lymphoma.
  • To elucidate the relationship between diffuse and nodular forms of ILL as developmental phases.
  • To compare the phenotypic and karyotypic profiles of ILL with related lymphoid neoplasms.

Summary:

  • Intermediate lymphocytic lymphoma exhibits unique pathomorphological and clinical characteristics.
  • The disease presents in both diffuse and nodular forms, representing distinct phases of development.
  • Phenotypic and karyotypic analyses reveal similarities to chronic lymphocytic leukemia, yet ILL follows a more malignant clinical course, akin to centrocytic lymphomas.

Impact:

  • Provides a clearer definition of intermediate lymphocytic lymphoma as a distinct disease entity.
  • Facilitates improved diagnostic accuracy and classification of lymphoid neoplasms.
  • Informs prognostic assessment and therapeutic strategies for patients with this lymphoma subtype.

Related Experiment Videos